Fundz

Factor Bioscience reported raising $1 Million in an initial SEC Form D filing, from an offering of $5 Million

RECENTLY ACQUIREDSep 25, 2025

Amount Raised

$1 Million

$1 Million sold, per SEC Form D (first sale Sep 15, 2025)

Round Type

Seed

CambridgeBiotechnologyHealth Care

Who to call at Factor Bioscience, and when

A new round usually means Factor Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Factor Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Factor Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Factor Bioscience. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Factor Bioscience

Location

Cambridge, Massachusetts, United States

About

Factor Bioscience was founded to pioneer new methods for controlling gene expression and cell fate. The company innovates across mRNA, gene editing, cell reprogramming, and nucleic acid delivery. With more than 150 granted patents, Factor Bioscience has helped unlock the potential of mRNA to treat disease and improve lives. Factor supports a model of unlimited discovery, believing that breakthroughs happen when scientists are given the freedom and resources to pursue bold ideas. At Factor Bioscience, science is the business. Partner with Factor Bioscience to build the next generation of cell therapies, gene therapies, and RNA therapeutics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Factor Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Factor Bioscience's next move

See what Strategic adds

Factor Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.